Skip to main content
Top
Published in: Rheumatology International 8/2011

01-08-2011 | Original Article

FCGR3A V(176) polymorphism for systemic lupus erythematosus susceptibility in Mexican population

Authors: Aniel J. L. Brambila-Tapia, Jorge I. Gámez-Nava, Laura González-López, Lucila Sandoval-Ramírez, Julio Medína-Díaz, Montserrat Maldonado, Sergio R. Gutierrez-Ureña, Gloria Martínez-Bonilla, Beatriz T. Martín-Márquez, Mónica Vázquez del Mercado, Arnulfo Nava-Zavala, José F. Muñoz-Valle, Mario Salazar-Páramo, Ingrid P. Dávalos-Rodríguez

Published in: Rheumatology International | Issue 8/2011

Login to get access

Abstract

The objective of this study is to establish whether there is an association between the presence of FCGR3A V(176) polymorphism with SLE or its manifestations. We included 94 patients according to the 1982 ACR criteria as well as 98 controls matched by age and gender. The 11 ACR diagnostic criteria were analyzed on the clinical files. The polymorphism FCGR3A V(176) was determined by direct sequencing. There was not an association between the polymorphism FCGR3A V(176) with SLE or its main manifestations. The allelic frequency for F(176) was: 0.80 and 0.72 in cases and controls, respectively (P = 0.09, IC95%: 0.42–1.07); and the genotypic frequency in the group of cases was: 0.65 for homozygotes F(176)/F(176), 0.30 for heterozygotes and 0.05 for the homozygotes V(176)/V(176), while for the control group it was 0.53, 0.39 and 0.08, respectively. The polymorphism FCGR3A V(176) is not associated with SLE or any of its manifestations in patients with SLE from the West of Mexico.
Literature
1.
go back to reference Krishnan S, Chowdhury B, Tsokos GC (2006) Autoimmunity in systemic lupus erythematosus, integration genes and biology. Semin Immunol 18:230–243PubMedCrossRef Krishnan S, Chowdhury B, Tsokos GC (2006) Autoimmunity in systemic lupus erythematosus, integration genes and biology. Semin Immunol 18:230–243PubMedCrossRef
2.
go back to reference Dijstelbloem HM, Bijl M, Fijnheer R et al (2000) Fcgamma receptor polymorphisms in systemic lupus erythematosus. Arthritis Rheum 43:2793–2800PubMedCrossRef Dijstelbloem HM, Bijl M, Fijnheer R et al (2000) Fcgamma receptor polymorphisms in systemic lupus erythematosus. Arthritis Rheum 43:2793–2800PubMedCrossRef
3.
go back to reference Kyogoku C, Dijstelbloem HM, Tsuchiya N et al (2002) Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus. Arthritis Rheum 46:1242–1254PubMedCrossRef Kyogoku C, Dijstelbloem HM, Tsuchiya N et al (2002) Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus. Arthritis Rheum 46:1242–1254PubMedCrossRef
4.
go back to reference Karassa FB, Trikalinos TA, Ioannidis JP (2003) The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis investigators and. Kidney Int 63:1475–1482PubMedCrossRef Karassa FB, Trikalinos TA, Ioannidis JP (2003) The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis investigators and. Kidney Int 63:1475–1482PubMedCrossRef
5.
go back to reference Zuñiga R, Ng Sonia, Peterson MGE et al (2001) Low-binding alleles of Fcγ receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in hispanic patients. Arthritis Rheum 44:361–367PubMedCrossRef Zuñiga R, Ng Sonia, Peterson MGE et al (2001) Low-binding alleles of Fcγ receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in hispanic patients. Arthritis Rheum 44:361–367PubMedCrossRef
6.
go back to reference Seligman VA, Suarez C, Lum R et al (2001) The Fcγ receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among caucasians but not non-caucasians. Arthritis Rheum 44:618–625PubMedCrossRef Seligman VA, Suarez C, Lum R et al (2001) The Fcγ receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among caucasians but not non-caucasians. Arthritis Rheum 44:618–625PubMedCrossRef
7.
go back to reference Magnusson V, Johanneson B, Lima G et al (2004) Both risk alleles for Fc gammaRIIA and Fc gammaRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun 5:130–137PubMedCrossRef Magnusson V, Johanneson B, Lima G et al (2004) Both risk alleles for Fc gammaRIIA and Fc gammaRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun 5:130–137PubMedCrossRef
8.
go back to reference Manger K, Repp R, Jansen M et al (2002) Receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis 61:786–792PubMedCrossRef Manger K, Repp R, Jansen M et al (2002) Receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis 61:786–792PubMedCrossRef
9.
go back to reference Edberg JC, Langefeld CD, Wu J et al (2002) Genetic linkage association of Fcγ receptor RIIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 46:2132–2139PubMedCrossRef Edberg JC, Langefeld CD, Wu J et al (2002) Genetic linkage association of Fcγ receptor RIIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 46:2132–2139PubMedCrossRef
10.
go back to reference Rubi-Castellanos R, Martínez-Cortés G, Francisco Muñoz-Valle J, et al (2009) Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico. Am J Phys Anthropol Rubi-Castellanos R, Martínez-Cortés G, Francisco Muñoz-Valle J, et al (2009) Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico. Am J Phys Anthropol
11.
go back to reference Tan PL, Borman GB, Wigley RD (1981) Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders. Rheumatol Int 1:147–149PubMedCrossRef Tan PL, Borman GB, Wigley RD (1981) Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders. Rheumatol Int 1:147–149PubMedCrossRef
12.
go back to reference Miller SA, Dykes DD, Polesky HP (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HP (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215PubMedCrossRef
Metadata
Title
FCGR3A V(176) polymorphism for systemic lupus erythematosus susceptibility in Mexican population
Authors
Aniel J. L. Brambila-Tapia
Jorge I. Gámez-Nava
Laura González-López
Lucila Sandoval-Ramírez
Julio Medína-Díaz
Montserrat Maldonado
Sergio R. Gutierrez-Ureña
Gloria Martínez-Bonilla
Beatriz T. Martín-Márquez
Mónica Vázquez del Mercado
Arnulfo Nava-Zavala
José F. Muñoz-Valle
Mario Salazar-Páramo
Ingrid P. Dávalos-Rodríguez
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1391-8

Other articles of this Issue 8/2011

Rheumatology International 8/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine